GeoVax Labs, Inc.

US$0.16As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GOVXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (89.09%)
Div yield —
ROE (891.59%)
Biotechnology
Beta (5Y) 3.86
PE TTM —
TSR TTM (98.88%)
Mkt cap US$1.436M
ROIC (523.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.176
11.51%
(51.22%)
Buy 10|7|6|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
5.84%
6.45%
4.45%
11.10%
Revenue$M
0.075
0.073
0.076
0.080
5.41%
4.08%
6.23%
12.12%
Peers (US$1.436M)
Cap (US$)
PE
1.575M
—
1.303M
—
Capital
TTM
5Y
10Y
Leveragex
2.738
(0.478)
(0.429)
EBIT/Intx
0.222
0.533
0.306
Own earn%
248.21
(26.85)
(29.07)
Sh yield%
18.80
19.60
19.48
Owners
Insiders/Inst%
12.69
75.05
Short interest%
2.29
SBC / revenue%
1.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
14–19
$1 testx
—
Incr. ROIC%
16